arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Jasper Therapeutics, Inc.

JSPR Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$0.50
▼ -0.9% Today
as of Oct 22, 16:49 ET
Last 30 days -21.64% Sep 14 → Oct 22
$0.46 $0.51 $0.56 $0.60 $0.65 Sep 14 Sep 22 Sep 29 Oct 07 Oct 14 Oct 22
Open
$0.50
High
$0.51
Low
$0.49
Volume
$72,244
Avg Vol
$1M
Mkt Cap
$20M
P/E (TTM)
—
Beta
—
52w High
$2.52
52w Low
$0.32
Div Yield
—
Shares Out
$28M

Recent Press Releases & News last 60 days · 4 items

Oct 15 · 12:00 PR GlobeNewswire
Jasper Therapeutics Announces Completion of Enrollment in First Cohort of Phase 2 Renal Basket Study Evaluating Vensobafusp Alfa (KP104) in IgA Nephropathy
Oct 7 · 12:00 PR GlobeNewswire
Jasper Therapeutics Announces Commencement of an Offer to Purchase Outstanding Warrants
Sep 15 · 20:05 PR GlobeNewswire
Jasper Therapeutics Announces Key Regulatory and Clinical Appointments
▸ Show all 4 press releases & news Free account →

JSPR earnings at a glance

The options market is pricing a move of about ±89.3% after the report, a range of roughly $0.05 to $0.95 from today's $0.50. Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±4.6% on average; after the most recent report on May 14, 2026 it moved +4.2%. That means options currently expect more movement than JSPR has typically delivered. JSPR beat the consensus EPS estimate in 1 of its last 4 reported quarters. Implied volatility is currently 8%. The share price of $0.50 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.32
$2.52
8% of range
Avg surprise (last 4)
-15.0%
Avg reaction (last 2)
+4.6%
100% positive
Latest IV / EM
756%
EM ±89.3% · $1 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-1.74$-1.33$-0.92$-0.51$-0.10 Actual $-1.62Actual $-1.47Actual $-1.60Actual $-1.03Actual $-0.97Actual $-1.24Actual $-1.41Est $-1.17Actual $-1.74Est $-1.20Actual $-1.13Est $-1.01Actual $-0.38Est $-0.46Actual $-0.10 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-27M$-20M$-14M$-8M$-1M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.10 — — — — financials
Thu May 14, 2026Mar/2026 $-0.38 $-0.46 +17.4% +73.0% +4.2% earnings
Mon Nov 10, 2025Sep/2025 $-1.13 $-1.01 -11.9% — — earnings
Wed Aug 13, 2025Jun/2025 $-1.74 $-1.20 -45.0% — — earnings
Mon May 12, 2025Mar/2025 $-1.41 $-1.17 -20.5% — +4.9% earnings
Mon Sep 30, 2024Sep 2024 $-1.24 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.97 — — — — financials
Sun Mar 31, 2024Mar 2024 $-1.03 — — — — financials
Sat Sep 30, 2023Sep 2023 $-1.60 — — — — financials
Fri Jun 30, 2023Jun 2023 $-1.47 — — — — financials
Fri Mar 31, 2023Mar 2023 $-1.62 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue————————
Cost of revenue$4M$4M—$9M$16M$10M—$9M
Gross profit————————
Operating income$-9M$-11M—$-19M$-27M$-22M—$-20M
Net income$-3M$-1M—$-19M$-27M$-21M—$-19M
EPS (diluted)$-0.10$-0.04—$-1.13$-1.74$-1.41—$-1.24

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$7M$14M$29M$51M$40M$49M$72M$93M
Inventory————————
Total current assets$12M$20M$35M$55M$43M$53M$76M$95M
Total assets$12M$21M$36M$57M$46M$58M$80M$99M
Long-term debt————————
Total liabilities$10M$18M$32M$46M$23M$15M$18M$16M
Total equity$1M$3M$4M$12M$24M$42M$62M$84M

Implied volatility — last 90 days

304%5371%10438%15505%20571% Jun 07 — IV 6301% · EM ±872.7%Jun 08 — IV 6995% · EM ±923.8%Jun 09 — IV 7624% · EM ±955.2%Jun 10 — IV 8023% · EM ±947.7%Jun 11 — IV 8545% · EM ±944.2%Jun 12 — IV 8224% · EM ±841.3%Jun 15 — IV 12659% · EM ±915.7%Jun 16 — IV 16471% · EM ±972.8%Jun 17 — IV 20572% · EM ±859.1%Jun 19 — IV 599% · EM ±132.4%Jun 30 — IV 741% · EM ±127.6%Jul 01 — IV 527% · EM ±88.0%Jul 02 — IV 794% · EM ±128.4%Jul 03 — IV 822% · EM ±128.4%Jul 06 — IV 1104% · EM ±153.0%Jul 07 — IV 1729% · EM ±228.4%Jul 08 — IV 1829% · EM ±229.2%Jul 20 — IV 1845% · EM ±435.8%Jul 21 — IV 1883% · EM ±437.8%Jul 22 — IV 2186% · EM ±500.0%Jul 23 — IV 2193% · EM ±493.2%Jul 24 — IV 2498% · EM ±552.0%Jul 27 — IV 2483% · EM ±518.5%Jul 28 — IV 2994% · EM ±612.5%Jul 29 — IV 3245% · EM ±649.9%Jul 30 — IV 3043% · EM ±596.0%Jul 31 — IV 3235% · EM ±619.0%Aug 03 — IV 3723% · EM ±659.7%Aug 14 — IV 1234% · EM ±136.4%Aug 31 — IV 397% · EM ±70.3%Sep 02 — IV 596% · EM ±99.5%Sep 04 — IV 632% · EM ±98.8%Sep 07 — IV 713% · EM ±98.8%Sep 08 — IV 534% · EM ±70.5%Sep 09 — IV 569% · EM ±71.3%Sep 10 — IV 604% · EM ±71.4%Sep 21 — IV 596% · EM ±124.4%Sep 28 — IV 316% · EM ±55.9%Sep 29 — IV 604% · EM ±103.9%Sep 30 — IV 628% · EM ±104.8%Oct 01 — IV 310% · EM ±50.2%Oct 02 — IV 305% · EM ±47.6%Oct 08 — IV 756% · EM ±89.3%

Sector peers

TCRX
TScan Therapeutics, Inc.
$20M $0.22-3.6%
ESLA
Estrella Immunopharma, Inc.
$21M $0.73+81.8%
DYAI
Dyadic International, Inc.
$17M $0.40+3.1%
BCDA
BioCardia, Inc.
$15M $0.93-10.7%
CVM
Cel-Sci Corporation
$26M $1.61+3.9%
INAB
IN8bio, Inc.
$14M $0.99-13.5%

JSPR earnings FAQ

What is JSPR's expected move for earnings?

Options currently price a move of about ±89.3%, or $0.45 per share either way from $0.50.

How does JSPR stock usually react to earnings?

Across the last 2 reports the average next-day move was ±4.6%, up 2 times and down 0 times.

What is JSPR's implied volatility?

JSPR's at-the-money implied volatility is about 8% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in